Bob Geng
Internal Medicine · Escondido, CA
CMS Profile ID: 288980 · NPI: 1356570758
Total Disclosed General Payments
$760,491.09
General-payment records
689
CMS Program Year
2025
Most of this (about 63%) was payments for services other than consulting, including faculty or speaking services outside continuing education.
Payments by Type
| Payment Type | Amount |
|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $482,351.31 |
| Travel and Lodging | $129,390.04 |
| Consulting Fee | $121,256.24 |
| Food and Beverage | $19,456.81 |
| Honoraria | $8,000.00 |
| Education | $36.69 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| GENZYME CORPORATION | $143,574.27 |
| GlaxoSmithKline, LLC. | $134,048.90 |
| Regeneron Healthcare Solutions, Inc. | $92,046.12 |
| Lilly USA, LLC | $77,651.85 |
| Incyte Corporation | $50,400.92 |
| Eli Lilly and Company | $35,890.14 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2025 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by exact NPI 1356570758 on the
official CMS Open Payments portal.
Verify this record with CMS
- Confirm the provider's exact NPI: 1356570758.
- Select program year 2025 and general payments in the CMS portal.
- Check individual payment records and their nature-of-payment categories.